sone).2 Our patient enjoyed a complete remission, with evidence of radiological improvement, for about 18 months and received no more drug treatment before the disease returned. Cohen's case had a flare of disease after three years.
The drawback to this form of treatment is undoubtedly the near certainty of side effects. Cohen's patient developed myelosuppression, as a result of which cyclophosphamide was substituted for nitrogen mustard. No mention was made of any other toxic effects. Our patient developed alopecia (temporary) and felt unwell for a few days after each course of treatment, but apart from this suffered no untoward side affects.
These case reports would appear to indicate that selected rheumatoid patients who have failed to respond to conventional second line antirheumatic drug treatment might benefit likewise and should not perhaps be denied the chance of a prolonged remission merely because they have not been dealt the 'Iymphoma passport' to effective treatment.
Thus it may be worth exploring the feasibility of treating severe but otherwise uncomplicated rheumatoid arthritis with similar drugs. Though We found a positive skin response to tuberculin in three of 19 HLA-DR4 positive patients with rheumatoid arthritis, in six of 19 HLA-DR4 positive controls, and in three of 17 HLA-DR4 negative controls (Fig. 1) .
From these relatively small numbers we suggest that in this population there is no relation between responsiveness to tuberculin and HLA-DR4 individuals with or without rheumatoid arthritis. Although Leiden is known in the Netherlands as the 'key town', in this case the Leiden women did not provide us with 'a clue to the pathogenesis of rheumatoid arthritis'.' As previously discussed,t one explanation for these negative results is that in contrast with patients with leprosy these women may respond to both common and species specific antigens, which may mask a possible immune response-gene effect for M tuberculosis antigens. Bahr et al, however, using the same skin test preparation have recently shown high responsiveness to tuberculin in HLA-DR4 patients with rheumatoid arthritis from Kuwait and a lack of ability of their patients to respond to common mycobacterial antigens similar to that observed in leprosy.5 Differences between the studies may reflect differences in environmental mycobacterial flora. We hope that our current efforts to define the M tuberculosis epitopes recognised by synovial 
